When Waiting Is Part of the ECT Decision

October 7, 2026 | The Psychiatric Record | Clinical Decisions

Calling electroconvulsive therapy a last resort can sound like a complete treatment plan. Try something else, allow more time, and return to the question later.

For an individual patient, that may be a reasonable course. But the phrase itself does not establish why waiting is reasonable, what improvement is expected, or what would make the delay unacceptable. It identifies a place in an imagined sequence without explaining the person's current needs.

The important distinction is between reviewing previous treatment and requiring a person to exhaust a sequence regardless of the consequences of delay.

NICE's adult depression guideline identifies three alternative reasons to consider ECT for severe depression: a person's preference informed by a helpful previous experience, a need for rapid response, or unsuccessful other treatments. Its example of urgency is life-threatening depression in someone who is not eating or drinking.

The guideline also calls for an individualized discussion of anesthesia and medical risks, cognitive effects, and the risks of not receiving ECT. It requires informed, unpressured consent, attention to the person's ability to make the decision, and recognition of the right to change their mind and withdraw consent.

Those are UK recommendations, not a universal legal pathway. The clinical point is that urgency and treatment history answer different questions. A list of unsuccessful medicines does not describe everything that matters now. Nor does a shorter list establish that postponement is harmless. NICE sets a stricter path for a repeat course when depression did not respond well to ECT before: reviewing the adequacy of that course, considering all other options and discussing the risks and benefits first.

A useful discussion makes the proposed alternative concrete. What is being offered during the interval? What benefit is reasonably being sought? How will the person be assessed while that plan proceeds? What change would prompt reconsideration?

For example, a plan to continue another treatment can identify the improvement being sought, when reassessment will occur, and what deterioration would prompt an earlier review. The interval then has a purpose the patient and treatment team can understand. The plan should also distinguish a clinical choice to wait from a delay in obtaining the preferred care.

These questions are editorial prompts for explaining a decision, not a scoring system or an instruction to select ECT. They should make room for a reasoned decision to proceed, defer, or choose another treatment.

The American Psychiatric Association's patient information gives high suicide risk and an inability to eat or drink adequately as examples of when a rapid response may be needed. It also describes assessment before treatment and the need to discuss expected benefits, risks and reasonable alternatives. It notes that ECT can affect learning and memory, including longer-lasting gaps in autobiographical memory for some people. The effects vary, and how treatment is administered can matter.

That makes memory concerns part of the decision, not an objection to be disposed of before the real conversation begins. The person may value particular memories, responsibilities or abilities in ways that a general description of treatment cannot capture. A clinician can explain the uncertainty without promising that every difficulty will be brief.

APA also states that the potential risks of ECT should be weighed against the risks of inadequately treated severe psychiatric illness and the benefits and risks of other treatment options. Discussing adverse effects without the consequences of continuing illness leaves the comparison incomplete. None of the options is free of risk. The useful question is how they fit this person's condition and priorities.

Urgency does not itself establish an inability to consent. APA notes that, when someone cannot provide informed consent, the applicable state law governs the process. This article does not set out that process or authorize treatment over an objection. Necessary clinical assessment and the applicable consent requirements remain essential.

A decision to defer ECT should be capable of being explained without relying on the words "last resort." Perhaps the person prefers another option after an informed discussion. Perhaps further assessment is needed. Perhaps the proposed alternative has a rationale that fits the current clinical situation.

Those explanations differ from waiting because a familiar sequence has not yet been completed. They also differ from a service delay, including time spent on insurance coverage or authorization, which APA notes varies by health plan. A lack of immediate access should not be described as though it proves that postponement is the preferred clinical choice.

The same standard applies when recommending ECT: explain why it is being considered now, what remains uncertain and what alternatives are meaningful. The aim is not to win an argument about the treatment's reputation. It is to give the patient an account of the actual choice, including the time that choice involves.

This is clinical commentary, not a new study report, a complete ECT protocol or a substitute for an individualized assessment. Sources reviewed October 7, 2026.

Educational Disclaimer: The Psychiatric Record provides general educational information for psychiatric and mental-health professionals. Content does not constitute medical, legal, regulatory, compliance, billing, or other professional advice; does not establish a standard of care; and is not a substitute for independent professional judgment. Appropriate assessment and treatment depend on the individual, setting, and current authoritative guidance. Patients should coordinate treatment decisions with their treating clinicians.